PANK-003 Cell Injection Combined With Standard Adjuvant Chemotherapy After Surgery in Patients With Stage IIIA NSCLC

NCT07043907 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

115

Enrollment

INDUSTRY

Sponsor class

Conditions

Stage IIIA Non-small Cell Lung Cancer

Interventions

DRUG: PANK-003 cell injection combined with standard postoperative adjuvant chemotherapy

Sponsor

Shenzhen Celconta Life Science Co., Ltd.